Procurement Magazine takes a look back at the biggest news from across the industry over the last seven days, including SAP, ...

Rising drug costs are shaking the foundation of Michigan’s health care industry, with the potential to push the market to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Ireland has pivoted to oppose contentious European Union reforms aimed at broadening access to new drugs and medicines, ...

For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...